Pulmonary effects of silver nanoparticle size, coating, and dose over time upon intratracheal instillation

Rona M. Silva, Donald S. Anderson, Lisa M. Franzi, Janice L. Peake, Patricia C. Edwards, Laura S. Van Winkle, Kent E Pinkerton

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Silver nanoparticles (Ag NPs) can be found in myriad consumer products, medical equipment/supplies, and public spaces. However, questions remain regarding the risks associated with Ag NP exposure. As part of a consortium-based effort to better understand these nanomaterials, this study examined how Ag NPs with varying sizes and coatings affect pulmonary responses at different time-points. Four types of Ag NPs were tested: 20nm (C20) and 110nm (C110) citrate-stabilized NPs, and 20 nm (P20) and 110nm (P110) PVP-stabilized NPs. Male, Sprague Dawley rats were intratracheally instilled with Ag NPs (0, 0.1, 0.5, or 1.0 mg/kg bodyweight [BW]), and bronchoalveolar lavage fluid (BALF) and lung tissues were obtained at 1, 7, and 21 days post-exposure for analysis of BAL cells and histopathology. All Ag NP types produced significantly elevated polymorphonuclear cells (PMNs) in BALF on Days 1, 7, and/or 21 at the 0.5 and/or 1.0 mg/kg BW dose(s). Histology of animals exposed to 1.0 mg/kg BW Ag NPs showed patchy, focal, centriacinar inflammation for all time-points; though neutrophils, macrophages, and/or monocytes were also found in the airway submucosa and perivascular regions at Days 1 and 7. Confocal microscopy of ethidium homodimer-stained lungs at Day 1 showed dead/dying cells at branch points along the main airway. By Day 21, only animals exposed to the high dose of C110 or P110 exhibited significant BALF neutrophilia and marked cellular debris in alveolar airspaces. Findings suggest that 110nm Ag NPs may produce lasting effects past Day 21 post instillation.

Original languageEnglish (US)
Pages (from-to)151-162
Number of pages12
JournalToxicological Sciences
Volume144
Issue number1
DOIs
StatePublished - Mar 1 2015

Fingerprint

Bronchoalveolar Lavage Fluid
Silver
Nanoparticles
Coatings
Lung
Fluids
Animals
Dimercaprol
Biomedical equipment
Histology
Consumer products
Nanostructures
Confocal microscopy
Macrophages
Nanostructured materials
Debris
Confocal Microscopy
Citric Acid
Sprague Dawley Rats
Rats

ASJC Scopus subject areas

  • Toxicology

Cite this

Pulmonary effects of silver nanoparticle size, coating, and dose over time upon intratracheal instillation. / Silva, Rona M.; Anderson, Donald S.; Franzi, Lisa M.; Peake, Janice L.; Edwards, Patricia C.; Van Winkle, Laura S.; Pinkerton, Kent E.

In: Toxicological Sciences, Vol. 144, No. 1, 01.03.2015, p. 151-162.

Research output: Contribution to journalArticle

Silva, Rona M. ; Anderson, Donald S. ; Franzi, Lisa M. ; Peake, Janice L. ; Edwards, Patricia C. ; Van Winkle, Laura S. ; Pinkerton, Kent E. / Pulmonary effects of silver nanoparticle size, coating, and dose over time upon intratracheal instillation. In: Toxicological Sciences. 2015 ; Vol. 144, No. 1. pp. 151-162.
@article{391187817c9249ee9f6685d23622229e,
title = "Pulmonary effects of silver nanoparticle size, coating, and dose over time upon intratracheal instillation",
abstract = "Silver nanoparticles (Ag NPs) can be found in myriad consumer products, medical equipment/supplies, and public spaces. However, questions remain regarding the risks associated with Ag NP exposure. As part of a consortium-based effort to better understand these nanomaterials, this study examined how Ag NPs with varying sizes and coatings affect pulmonary responses at different time-points. Four types of Ag NPs were tested: 20nm (C20) and 110nm (C110) citrate-stabilized NPs, and 20 nm (P20) and 110nm (P110) PVP-stabilized NPs. Male, Sprague Dawley rats were intratracheally instilled with Ag NPs (0, 0.1, 0.5, or 1.0 mg/kg bodyweight [BW]), and bronchoalveolar lavage fluid (BALF) and lung tissues were obtained at 1, 7, and 21 days post-exposure for analysis of BAL cells and histopathology. All Ag NP types produced significantly elevated polymorphonuclear cells (PMNs) in BALF on Days 1, 7, and/or 21 at the 0.5 and/or 1.0 mg/kg BW dose(s). Histology of animals exposed to 1.0 mg/kg BW Ag NPs showed patchy, focal, centriacinar inflammation for all time-points; though neutrophils, macrophages, and/or monocytes were also found in the airway submucosa and perivascular regions at Days 1 and 7. Confocal microscopy of ethidium homodimer-stained lungs at Day 1 showed dead/dying cells at branch points along the main airway. By Day 21, only animals exposed to the high dose of C110 or P110 exhibited significant BALF neutrophilia and marked cellular debris in alveolar airspaces. Findings suggest that 110nm Ag NPs may produce lasting effects past Day 21 post instillation.",
author = "Silva, {Rona M.} and Anderson, {Donald S.} and Franzi, {Lisa M.} and Peake, {Janice L.} and Edwards, {Patricia C.} and {Van Winkle}, {Laura S.} and Pinkerton, {Kent E}",
year = "2015",
month = "3",
day = "1",
doi = "10.1093/toxsci/kfu265",
language = "English (US)",
volume = "144",
pages = "151--162",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Pulmonary effects of silver nanoparticle size, coating, and dose over time upon intratracheal instillation

AU - Silva, Rona M.

AU - Anderson, Donald S.

AU - Franzi, Lisa M.

AU - Peake, Janice L.

AU - Edwards, Patricia C.

AU - Van Winkle, Laura S.

AU - Pinkerton, Kent E

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Silver nanoparticles (Ag NPs) can be found in myriad consumer products, medical equipment/supplies, and public spaces. However, questions remain regarding the risks associated with Ag NP exposure. As part of a consortium-based effort to better understand these nanomaterials, this study examined how Ag NPs with varying sizes and coatings affect pulmonary responses at different time-points. Four types of Ag NPs were tested: 20nm (C20) and 110nm (C110) citrate-stabilized NPs, and 20 nm (P20) and 110nm (P110) PVP-stabilized NPs. Male, Sprague Dawley rats were intratracheally instilled with Ag NPs (0, 0.1, 0.5, or 1.0 mg/kg bodyweight [BW]), and bronchoalveolar lavage fluid (BALF) and lung tissues were obtained at 1, 7, and 21 days post-exposure for analysis of BAL cells and histopathology. All Ag NP types produced significantly elevated polymorphonuclear cells (PMNs) in BALF on Days 1, 7, and/or 21 at the 0.5 and/or 1.0 mg/kg BW dose(s). Histology of animals exposed to 1.0 mg/kg BW Ag NPs showed patchy, focal, centriacinar inflammation for all time-points; though neutrophils, macrophages, and/or monocytes were also found in the airway submucosa and perivascular regions at Days 1 and 7. Confocal microscopy of ethidium homodimer-stained lungs at Day 1 showed dead/dying cells at branch points along the main airway. By Day 21, only animals exposed to the high dose of C110 or P110 exhibited significant BALF neutrophilia and marked cellular debris in alveolar airspaces. Findings suggest that 110nm Ag NPs may produce lasting effects past Day 21 post instillation.

AB - Silver nanoparticles (Ag NPs) can be found in myriad consumer products, medical equipment/supplies, and public spaces. However, questions remain regarding the risks associated with Ag NP exposure. As part of a consortium-based effort to better understand these nanomaterials, this study examined how Ag NPs with varying sizes and coatings affect pulmonary responses at different time-points. Four types of Ag NPs were tested: 20nm (C20) and 110nm (C110) citrate-stabilized NPs, and 20 nm (P20) and 110nm (P110) PVP-stabilized NPs. Male, Sprague Dawley rats were intratracheally instilled with Ag NPs (0, 0.1, 0.5, or 1.0 mg/kg bodyweight [BW]), and bronchoalveolar lavage fluid (BALF) and lung tissues were obtained at 1, 7, and 21 days post-exposure for analysis of BAL cells and histopathology. All Ag NP types produced significantly elevated polymorphonuclear cells (PMNs) in BALF on Days 1, 7, and/or 21 at the 0.5 and/or 1.0 mg/kg BW dose(s). Histology of animals exposed to 1.0 mg/kg BW Ag NPs showed patchy, focal, centriacinar inflammation for all time-points; though neutrophils, macrophages, and/or monocytes were also found in the airway submucosa and perivascular regions at Days 1 and 7. Confocal microscopy of ethidium homodimer-stained lungs at Day 1 showed dead/dying cells at branch points along the main airway. By Day 21, only animals exposed to the high dose of C110 or P110 exhibited significant BALF neutrophilia and marked cellular debris in alveolar airspaces. Findings suggest that 110nm Ag NPs may produce lasting effects past Day 21 post instillation.

UR - http://www.scopus.com/inward/record.url?scp=84924515320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924515320&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfu265

DO - 10.1093/toxsci/kfu265

M3 - Article

C2 - 25628415

AN - SCOPUS:84924515320

VL - 144

SP - 151

EP - 162

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -